See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875320_2026_Vertex_Pharmaceuticals_INC_MA.pdf
Logs
Graph
Absolute values for 0000875320, Vertex Pharmaceuticals INC MA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,201,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,512,200,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 12,929,800,000 |
| 4 | LiabilitiesCurrent | 3,861,200,000 |
| 5 | LiabilitiesNoncurrent | 3,116,000,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,859,938,867 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,891,854,945 |
| 9 | ResearchAndDevelopmentExpense | 5,770,857,530 |
| 10 | remainder_Expenses | 993,355,454 |
| 11 | remainder_Revenues | 14,913,414,431 |
| 12 | remainder_NetIncome | 483,865,842 |
| 13 | remainder_ComprehensiveNetIncome | -650,895 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,643,000,000 |
| 1 | Liabilities | 6,977,200,000 |
| 2 | Expenses | 11,516,006,796 |
| 3 | Revenues | 14,913,414,431 |
| 4 | StockholdersEquity | 18,665,800,000 |
| 5 | NetIncome | 3,881,273,477 |
| 6 | ComprehensiveNetIncome | 3,880,948,030 |
| 7 | BaseVar | 29,767,068,982 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.73 |
| 9 | EconomicCapitalRatio | 3.51 |
Edgar->Model Mapping
Feature Distribution
Change over Time
